4th Annual MarketsandMarkets Epigenetics Congress announced with Speaker Line-up


Posted May 23, 2019 by MarketsandMarkets-Conferences

MarketsandMarkets is organizing its 4th Annual MarketsndMarkets Epigenetics Congress in London on 3rd – 4th October 2019, discussing solutions to challenges like drug discovery, identification of molecular inhibitors, gene modification and analysis.

 
– MarketsandMarkets presents to you the 4th Annual MarketsandMarkets Epigenetics Congress to be held on 3-4 October 2019 in London, UK. The 2-day event will host more than 25+ expert speakers, 15+ sponsors, 120+ professionals working on epigenetics, developmental epigenetics, epidemiology, molecular biology, genetics and genomics and translational sciences.

The 2-day two stream congress will focus on discussing solution to challenges like drug discovery, identification of molecular inhibitors, gene modification and analysis and latest advancement in epigenetics research. The expected attendance of 120+ delegates will include leading expert professionals from University and Epigenetics industry working on Epigenetics, Developmental Epigenetics, Epidemiology, Molecular Biology, Developmental Biology, Biochemistry, Genetics and Genomics and Translational Sciences.

The congress will serve as a unique platform to witness epigenetics based clinical development and combinational therapies, with a special emphasis on transcriptional analysis and molecular profiling. Speaker organization such as GSK, 4SC, University of Groningen, Novartis Institute of Biomedical Research, Rodin Therapeutics, NARCIS, University of Oxford, Imperial College and more will discuss the solutions to challenges in drug discovery, gene modification etc.

Emphasizing on Clinical epigenetics, Gavin Reynolds, Professor Emeritus, Queen’s University Belfast, UK will present on topic - DNA methylation as an epigenetic factor in psychiatric disorders and their treatment. Christopher Schofield, Head of Organic Chemistry, University of Oxford, UK will present on challenges in targeting histone demethylases. Alfredo Budillon, Chief Experimental Pharmacology Unit Department of Research, Istituto Nazionale Tumori, Italy will share speak on Development of novel therapeutic anticancer approach with HDAC inhibitors: from the bench to the bedside. Ronan Murphy, Associate Editor, Clinical Epigenetic, Dublin City University, Ireland will present on Platelets: Functional biomarkers of epigenetic drift.

The event overview, registration details and complete speaker list are available on the official website. You can also download the complete agenda to identify the potential interest in the conference on this page – https://bit.ly/2URGDJU or you can directly email on [email protected] asking for more details, your queries and provide feedback.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MarketsandMarkets - Conferences
Phone 2048598285
Business Address pune
Country India
Categories Health , Science
Tags clinical epigenetics , epigenetics
Last Updated May 23, 2019